Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. V. van Dam · SciRah

Researcher profile · Semantic Scholar

K. V. van Dam

Share profile

K. V. van Dam — researcher profile on SciRah

h-index: 11
Works: 33
Citations: 549

Most-cited papers

Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
L. Boekel, M. Steenhuis, F. Hooijberg, Y. Besten +20 more
2021The Lancet Rheumatology154 citations Open access
Semantic Scholar
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
L. Wieske, K. V. van Dam, M. Steenhuis, E. Stalman +71 more
2022The Lancet Rheumatology114 citations Open access
Semantic Scholar
Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
L. Boekel, L. Kummer, K. V. van Dam, F. Hooijberg +13 more
2021The Lancet Rheumatology55 citations Open access
Semantic Scholar
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies
L. Boekel, E. Stalman, L. Wieske, F. Hooijberg +82 more
2022The Lancet Rheumatology43 citations Open access
Semantic Scholar
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
L. Wieske, L. Kummer, K. V. van Dam, E. Stalman +49 more
2022BMC Medicine20 citations Open access
Semantic Scholar
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
K. V. van Dam, L. Wieske, E. Stalman, L. Kummer +54 more
2023Journal of Autoimmunity17 citations Open access
Semantic Scholar
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases
E. Stalman, L. Wieske, K. V. van Dam, L. Kummer +55 more
2022Annals of the Rheumatic Diseases17 citations Open access
Semantic Scholar
SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis
Z. V. van Kempen, E. Stalman, M. Steenhuis, L. Kummer +9 more
2022Journal of Neurology Neurosurgery & Psychiatry17 citations Open access
Semantic Scholar
Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273
N. Verstegen, R. Hagen, J. van den Dijssel, L. Kuijper +25 more
2022eLife16 citations Open access
Semantic Scholar
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod
Virginia Palomares-Cabeza, L. Kummer, L. Wieske, R. Hagen +17 more
2022Neurology: Neuroimmunology & Neuroinflammation16 citations Open access
Semantic Scholar
Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination
Anika M. Valk, J. Keijser, K. V. van Dam, E. Stalman +26 more
2024Allergy. European Journal of Allergy and Clinical Immunology15 citations Open access
Semantic Scholar
mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses.
J. van den Dijssel, M. Duurland, Veronique Al Konijn, L. Kummer +25 more
2024Journal of Autoimmunity10 citations Open access
Semantic Scholar
Ocrelizumab Concentration Is a Good Predictor of SARS‐CoV‐2 Vaccination Response in Patients with Multiple Sclerosis
Z. V. van Kempen, L. Hogenboom, Alyssa A. Toorop, M. Steenhuis +14 more
2022Annals of Neurology9 citations Open access
Semantic Scholar
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
K. V. van Dam, A. Volkers, L. Wieske, E. Stalman +53 more
2023BMC Infectious Diseases6 citations Open access
Semantic Scholar
Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapy
Anika M. Valk, J. Koers, N. Derksen, L. Hogenboom +64 more
2025Scientific Reports5 citations Open access
Semantic Scholar
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination
N. Verstegen, R. Hagen, Christine Kreher, L. Kuijper +25 more
2024Journal of Neurology Neurosurgery & Psychiatry5 citations Open access
Semantic Scholar
Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination
K. V. van Dam, L. Hogenboom, E. Stalman, L. Kummer +11 more
2022Frontiers in Neurology5 citations Open access
Semantic Scholar
Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID
L. Kummer, Laura Fernandez Blanco, Christine Kreher, A. Bos +26 more
2024RMD Open4 citations Open access
Semantic Scholar
Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection
S. Keijzer, Nienke Oskam, Pleuni Ooijevaar-de Heer, M. Steenhuis +13 more
2024Frontiers in Immunology4 citations Open access
Semantic Scholar
Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatment
J. Keijser, E. Stalman, L. Wieske, M. Steenhuis +72 more
2025EBioMedicine3 citations Open access
Semantic Scholar
TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination
L. Kummer, L. Kuijper, Laura Fernandez Blanco, A. Bos +25 more
2025RMD Open3 citations Open access
Semantic Scholar
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after repeated SARS-CoV-2 mRNA vaccination
Anika M. Valk, J. Keijser, K. V. van Dam, E. Stalman +26 more
2023medRxiv3 citations Open access
Semantic Scholar
Impact of COVID‐19 disease and vaccination on dermatological immune‐mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy
Nicoline F. van Buchem-Post, W. Ouwerkerk, E. Stalman, K. V. van Dam +62 more
2025Journal of dermatology (Print)2 citations Open access
Semantic Scholar
Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod
Zoé le van Kempen, K. V. van Dam, J. Keijser, E. Stalman +10 more
2023Multiple Sclerosis2 citations Open access
Semantic Scholar
Heterogeneous Activated B Cell Compartments Arising Early and Transiently After SARS‐CoV‐2 Vaccination
Laura Fernandez Blanco, L. Kuijper, L. Kummer, N. Verstegen +19 more
2026European Journal of Immunology1 citations Open access
Semantic Scholar
SARS‐CoV‐2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults
Lisan H. Kuijper, L. Kummer, L. Blanco, K. van der Straten +19 more
2026European Journal of Immunology1 citations Open access
Semantic Scholar
Clinical and humoral responses after SARS-CoV-2 breakthrough infections in patients with immunosuppressants.
E. Stalman, L. Wieske, J. Keijser, K. V. van Dam +56 more
2024Journal of Allergy and Clinical Immunology1 citations Open access
Semantic Scholar
DOP27 Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study
A. Volkers, L. Wieske, K. V. van Dam, M. Steenhuis +26 more
2022Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
Patient‐reported daily functioning after SARS‐CoV‐2 vaccinations in autoimmune neuromuscular diseases
K. V. van Dam, L. Wieske, E. Stalman, L. Kummer +15 more
2024European Journal of Neurology0 citations Open access
Semantic Scholar
SARS-CoV-2 Delta Breakthrough Infections in Vaccinated Patients with Immune-Mediated Inflammatory Diseases Using Immunosuppressants – Data from Two Controlled Prospective Cohort Studies
L. Boekel, E. Stalman, L. Wieske, F. Hooijberg +66 more
2022Social Science Research Network0 citations Open access
Semantic Scholar
POS1256 RISK FACTORS FOR SHORT-TERM ADVERSE EVENT IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES
L. Kummer, L. Wieske, E. Stalman, K. V. van Dam +12 more
2022Annals of the Rheumatic Diseases0 citations Open access
Semantic Scholar
Antibody Development after SARS-CoV-2 Vaccinations in Elderly Patients with Autoimmune Diseases: Data From a Prospective Controlled Cohort Study
L. Boekel, M. Steenhuis, F. Hooijberg, Y. Besten +20 more
2021Social Science Research Network0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Wieske×33
Invite
L. Wieske — researcher profile on SciRah
L. Kummer×32
Invite
L. Kummer — researcher profile on SciRah
T. Rispens×32
Invite
T. Rispens — researcher profile on SciRah
E. Stalman×31
Invite
E. Stalman — researcher profile on SciRah

×31

Invite

F. Eftimov — researcher profile on SciRah

M. Steenhuis×29

Invite

M. Steenhuis — researcher profile on SciRah

A. ten Brinke×29

Invite

A. ten Brinke — researcher profile on SciRah

S. V. van Ham×27

Invite

S. V. van Ham — researcher profile on SciRah

Invite

L. Boekel — researcher profile on SciRah

J. Killestein×24

Invite

J. Killestein — researcher profile on SciRah

Z. V. van Kempen×21

Invite

Z. V. van Kempen — researcher profile on SciRah

N. Verstegen×17

Invite

N. Verstegen — researcher profile on SciRah